Clinical Trial Update: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

View source ↗

Summary

Takeda-sponsored cohort study assessed cancer incidence among people with type 2 diabetes treated with pioglitazone; results were posted in January 2017. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2, Cancer | Status: COMPLETED | Results posted: 2017-01-10